NCT03806673 is a Phase 4 clinical trial of marcaine in Incidence, sponsored by Ain Shams University.

Who is sponsoring NCT03806673?

NCT03806673 is sponsored by Ain Shams University.

What drugs are being tested in NCT03806673?

Interventions in NCT03806673: marcaine.

What condition does NCT03806673 study?

NCT03806673 studies Incidence, Unilateral, Epidural Block.

Is NCT03806673 still recruiting?

NCT03806673 is currently completed. Last updated 16 January 2019.

Last reviewed 2019-01-16 · How we verify

NCT03806673

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is There a Relation Between Unilateral Epidural Block and Repeated Epidural Anesthesia?

Completed Phase 4 Last updated 16 January 2019

What this trial tests

Phase 4 trial testing marcaine in Incidence in 140 participants. Completed in 11 September 2018.

Timeline

5 February 2018

Primary endpoint
1 September 2018

11 September 2018

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	140
Start date	5 February 2018
Primary completion	1 September 2018
Estimated completion	11 September 2018
Sites	1 location across Egypt

Drugs / interventions tested

marcaine

Conditions studied

Incidence — all drugs for Incidence →
Unilateral — all drugs for Unilateral →
Epidural Block — all drugs for Epidural Block →

Sponsor

Ain Shams University

Who can join

Adults 20 to 40, female only, with Incidence or Unilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

epidural block is today the most common method of pain relief during labor. With increased use of epidural analgesia, many women are found in the second or third pregnancy and require repeated epidural analgesia. But there was a higher incidence of unilateral blockade among women receiving their repeated epidural which causes patient unsatisfaction. Objectives: Examination of the performance and outcome of women receiving their first versus repeated epidural block. Patients and methods: The study included 140 American Society of Anesthesiologists (ASA) Physical Status II patients (age range 20 to 40 years) and scheduled for normal vaginal delivery. The patients were divided randomly into two equal groups. Group (A) in which 70 women primipara subjected to their first epidural block while group (B) in which 70 women multipara subjected to their repeated epidural block. For each patient, the following data were collected: demographic data, details of labor (gestation, cervical dilatation), visual analogue scale (VAS) before the epidural and 30 minutes after injection of local anesthetic and incidence of unilateral block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03806673 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 16 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03806673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing